Kazia Therapeutics (KZIA) Gains from Investment Securities (2020 - 2022)
Kazia Therapeutics (KZIA) posted Gains from Investment Securities of $145620.3 for Q4 2022, up 171.09% on a QoQ basis from -$204838.4 in Q4 2021, and up 171.09% year-over-year from $53716.5 in Q4 2021.
Kazia Therapeutics (KZIA) Gains from Investment Securities (2020 - 2022) Analysis & Trends
Kazia Therapeutics' Gains from Investment Securities history runs 3 years deep, the most recent figure standing at $145620.3 for Q4 2022.
- Quarterly Gains from Investment Securities rose 171.09% year-over-year to $145620.3 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was -$2171.2 (down 100.68% YoY) and the FY2017 annual result came in at $576104.0, changed N/A from the prior year.
- Gains from Investment Securities was $145620.3 for Q4 2022 at Kazia Therapeutics, up from -$204838.4 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $145620.3 in Q4 2022 and bottomed at -$204838.4 in Q4 2021.
- A 3-year average of -$73120.5 and a median of -$160143.4 in 2020 frame the typical range for Gains from Investment Securities.
- Annual changes were most pronounced in 2021 — Gains from Investment Securities decreased 27.91% — and 2022, when it soared 171.09%.
- Kazia Therapeutics' Gains from Investment Securities stood at -$160143.4 in 2020, then fell by 27.91% to -$204838.4 in 2021, then surged by 171.09% to $145620.3 in 2022.
- Business Quant data shows KZIA's Gains from Investment Securities at $145620.3 in Q4 2022, -$204838.4 in Q4 2021, and -$160143.4 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Kazia Therapeutics | 19.19 Bn | 19.19 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 145,620.34 |
| Dec 31, 2022 | 145,620.34 |
| Dec 31, 2021 | -204,838.38 |
| Dec 31, 2021 | -204,838.38 |
| Dec 31, 2020 | -160,143.42 |
| Dec 31, 2020 | -160,143.42 |